Applied Filters
Emcure prevails against ‘fairytale’ accusations
Emcure fends off COVID-19 trade secrets suit in Washington | A US biotech had inked a short-lived deal with Indian generic pharma company’s subsidiary.
EPO revokes Moderna's COVID-19 vaccine patent
The European Patent Office hands a win to BioNTech and Pfizer in coronavirus vaccine dispute | US biotech plans to appeal decision affecting mRNA patent.
10x Genomics awarded $31m in key ruling over NanoString
District court’s verdict found NanoString infringed on seven patents related to protein detection tech | Marks the third victory for 10x Genomics in the last six months | NanoString ‘must drop the charade’ says 10x CEO.
AbbVie accused of delay tactics in $1.3bn Humira dispute
Big pharma company relies on procedural arguments to fend off a complaint alleging that it engaged in excessive pricing | Feud centres on one of the most successful blockbuster drugs of all time.
Neurocrine resolves dispute over Huntington's treatment
Neuroscience-focused biopharma ends litigation with four companies | Companies can introduce generic alternatives in the future.
USPTO aims to fend off Fintiv challenge at SCOTUS
Controversial rule precludes a patent review if there is parallel litigation | Big pharma and tech companies insist the rule is “arbitrary and capricious” | US agency backs Vidal’s authority, calling a proposed intervention “unnecessary”.
Taiwan company fails to overturn PTAB decision over eye treatment patent
Federal Circuit rejects appeal in patent dispute with California’s Cloudbreak Theraputics | Court stated failure to prove concrete injury.
Spinal implant inventor sues over four ‘infringed’ products
RSB Spine files patent infringement lawsuit against competitors over spinal implant products | Plaintiff claims the defendants had knowledge of patent infringement.
Foley Hoag completes IP team hire
Amy Baker Mandragouras’ (pictured) team follow her from Cooley | New counsel’s scientific expertise is “second-to-none” | Team has experience in strategic counselling and biotech patent portfolios.
Hogan Lovells hires Hatch-Waxman litigators
The firm's newest life sciences partners are patent litigators in biotech and pharma fields | Duo have secured Hatch-Waxman litigation victories.
